Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

Non-small Cell Lung Cancer Study US75 (Z-PACT)

See Locations Near You

Summary

This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or Female patients at least of 18 years old
Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
Women must not be pregnant or attempting to become pregnant
Able and willing to sign informed consent

Exclusion Criteria:

Patients with cancer that has spread to the bone
Patients with cancer that has spread to the brain who are receiving treatment
Patients with kidney disease
Patients treated with other investigational drugs

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

250

Study ID:

NCT00086268

Recruitment Status:

Completed

Sponsor:

Novartis Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 78 Locations for this study

See Locations Near You

Load More

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

250

Study ID:

NCT00086268

Recruitment Status:

Completed

Sponsor:


Novartis Pharmaceuticals

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider